ESG Trends: Weight Loss Pharma
The ESG perspectives of Weight Loss industry are comprehensively identified, analyzed and presented in ten reports.
Series of Reports Offered
For companies, regulators and investors:
For broader interest groups:
This series benefits:
- Company teams engaged in addressing ESG aspects of weight loss drugs, therapies and treatments
- ESG team compiling their ESG reports for their weight loss company
- Regulators and policymakers in gaining a comprehensive ESG outlook towards the weight loss industry
- General readers interested in imbibing sustainable weight loss living
- Advocators in updating with the most current research on weight loss
